The DOI matches its Crossref record; 303 of the 303 references it cites were found in a registry or an index.
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–303 of 303
Ott, V., Benedict, C., Schultes, B., Born, J., & Hallschmid, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01490.x · Cited by 139
Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors
Navarro, I., Leibush, B. N., Moon, T. W., Plisetskaya, E. M., Baños, N., Méndez, E., Planas, J. V., & Gutiérrez, J. (1999) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(98)10163-3 · Cited by 139
Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
Correia, S. C., Santos, R. X., Santos, M. S., Casadesús, G., LaManna, J. C., Perry, G. L., Smith, M. A., & Moreira, P. I. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040006 · Cited by 139
Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation
Polter, A. M., Yang, S., Zmijewska, A. A., van Groen, T., Paik, J.-H., DePinho, R. A., Peng, S. L., Jope, R. S., & Li, X. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.005 · Cited by 136
Okada, S., Kao, A. W., Ceresa, B. P., Blaikie, P., Margolis, B. L., & Pessin, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28042 · Cited by 134
Christopher, R. J., Covington, P. S., Davenport, M. P., Fleck, P. R., Mekki, Q. A., Wann, E. R., & Karim, A. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.03.005 · Cited by 129
Quesada, A., Romeo, H. E., & Micevych, P. E. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21358 · Cited by 129
Costa, R., Ferreira-da-Silva, F., Saraiva, M., & Cardoso, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002899 · Cited by 128
Tokutake, T., Kasuga, K., Yajima, R., Sekine, Y., Tezuka, T., Nishizawa, M., & Ikeuchi, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348300 · Cited by 127
Sonntag, W. E., Lynch, C. D., Bennett, S., Khan, A., Thornton, P. L., Cooney, P. T., Ingram, R. L., McShane, T. M., & Brunso-Bechtold, J. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00192-4 · Cited by 127
Nutritional Status, Cognition, and Survival
Dagon, Y., Avraham, Y., Magen, I., Gertler, A., Ben‐Hur, T., & Berry, E. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507607200 · Cited by 127
García‐Segura, L. M., Rodríguez, J., & Torres‐Alemán, I. (1997) · Journal of Neurocytology · doi:10.1023/a:1018581407804 · Cited by 125
Wegiel, J., Wang, K. C., Tarnawski, M., & Lach, B. (2000) · Acta Neuropathologica · doi:10.1007/s004010000199 · Cited by 124
Lesort, M. J., & Johnson, G. V. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00200-1 · Cited by 123
The glucagon-like peptides: a double-edged therapeutic sword?
Perry, T., & Greig, N. H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00160-3 · Cited by 122
Baskin, D. G., Woods, S. C., West, D. B., van Houten, M., Posner, B. I., Dorsa, D. M., & Porte, D. (1983) · Endocrinology · doi:10.1210/endo-113-5-1818 · Cited by 122
Insulin-induced phosphorylation on FKHR (Foxo1) targets to proteosomal degradation
Matsuzaki, H. (2003) · Medical Entomology and Zoology · Cited by 122
Wang, X., Zhai, Y., Xu, L., Qiao, C., Sun, X., Ding, J., Lu, M., & Hu, G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.001 · Cited by 121
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice
Bousquet, M., St‐Amour, I., Vandal, M., Julien, P., Cicchetti, F., & Calon, F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.009 · Cited by 121
Sarkar, S., Fekete, C., Légrádi, G., & Lechan, R. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03117-2 · Cited by 119
Rachman, J., Gribble, F. M., Barrow, B. A., Lévy, J., Buchanan, K. D., & Turner, R. C. (1996) · Diabetes · doi:10.2337/diab.45.11.1524 · Cited by 119
Insulin-Like Growth Factors as Mediators of Functional Plasticity in the Adult Brain
Torres‐Alemán, I. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978707 · Cited by 116
Ma, T., Du, X., Pick, J. E., Sui, G., Brownlee, M., & Klann, E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2107-12.2012 · Cited by 114
Offen, D., Shtaif, B., Hadad, D., Weizman, A., Melamed, E., & Gil‐Ad, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02344-8 · Cited by 113
Choi, J., Jang, E.-H., Park, C., & Kang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.008 · Cited by 112
Yamauchi, K., & Pessin, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47396-6 · Cited by 111
Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS
Finkelstein, A., Kunis, G., Seksenyan, A., Ronen, A., Berkutzki, T., Azoulay, D., Koronyo‐Hamaoui, M., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022374 · Cited by 111
McIntyre, R. S., Powell, A. M., Kaidanovich-Beilin, O., Soczynska, J. K., Alsuwaidan, M., Woldeyohannes, H. O., Kim, A. S., & Gallaugher, L. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.021 · Cited by 110
Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK
Barthélémy, C., Henderson, C. E., & Pettmann, B. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-48 · Cited by 110
An Integrated and Unifying Hypothesis for the Metabolic Basis of Sporadic Alzheimer's Disease
Erol, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13302 · Cited by 108
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
Kappe, C., Tracy, L. M., Patrone, C., Iverfeldt, K., & Sjöholm, Å. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-276 · Cited by 107
Tau Is Hyperphosphorylated in the Insulin-Like Growth Factor-I Null Brain
Cheng, C. M., Tseng, V., Wang, J., Wang, D., Matyakhina, L., & Bondy, C. A. (2005) · Endocrinology · doi:10.1210/en.2005-0063 · Cited by 107
Guan, J., Krishnamurthi, R., Waldvogel, H. J., Faull, R. L. M., CLARK, R. G., & Gluckman, P. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01988-0 · Cited by 105
Kanse, S. M., Kreymann, B., Ghatei, M. A., & Bloom, S. R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81063-9 · Cited by 104
Quantitative Autoradiographic Evidence for Insulin Receptors in the Choroid Plexus of the Rat Brain
Baskin, D. G., Brewitt, B., Davidson, D. A., Paquette, T. L., Figlewicz, D. P., Lewellen, T. K., Graham, M. K., Woods, S. G., & Dorsa, D. M. (1986) · Diabetes · doi:10.2337/diab.35.2.246 · Cited by 104
Werther, G. A., Hogg, A., Oldfield, B. J., McKinley, M. J., Figdor, R., & Mendelsohn, F. A. O. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00131.x · Cited by 102
A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis
Boucher, J., Macotela, Y., Bézy, O., Mori, M. A., Kriauciunas, K. M., & Kahn, C. R. (2010) · Science Signaling · doi:10.1126/scisignal.2001173 · Cited by 102
Increased Circulating Insulin-like Growth Factor-1 in Late-onset Alzheimer's Disease
Vardy, E. R. L. C., Rice, P. J., Bowie, P. C. W., Holmes, J. D., Grant, P. J., & Hooper, N. M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12401 · Cited by 100
Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation
Copley, K., McCowen, K. M., Hiles, R., Nielsen, L. L., Young, A. J., & Parkes, D. G. (2006) · Current Drug Metabolism · doi:10.2174/138920006776873490 · Cited by 100
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk
Powers, K. M., Smith‐Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.004 · Cited by 99
Fura, A., Khanna, A. K., Vyas, V. P., Koplowitz, B., Chang, S., Caporuscio, C., Boulton, D. W., Christopher, L. J., Chadwick, K. D., Hamann, L. G., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026088 · Cited by 98
Tong, M., Dong, M., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0995 · Cited by 97
Alzheimer culprits: Cellular crossroads and interplay
Claeysen, S., Cochet, M., Donneger, R., Dumuis, A., Bockaert, J., & Giannoni, P. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.05.008 · Cited by 96
Meissner, W. G., Hill, M. P., Tison, F., Gross, C. E., & Bézard, E. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.003 · Cited by 96
Self-citationTorres‐Alemán, I., Barrios, V., & Berciano, J. (1998) · Neurology · doi:10.1212/wnl.50.3.772 · Cited by 96
Unger, J. W., Moss, A., & Livingston, J. N. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90049-t · Cited by 95
Diabetes and risk of Parkinson's disease
Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., & Pezzoli, G. (2012) · Movement Disorders · doi:10.1002/mds.25211 · Cited by 94
Fuchs, H., Binder, R., & Greischel, A. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.662 · Cited by 93
Perry, T., & Greig, N. H. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4605 · Cited by 92
Schechter, R., Beju, D., Gaffney, T. J., Schaefer, F., & Whetsell, L. H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00664-6 · Cited by 92
Insulin Levels are Decreased in the Cerebrospinal Fluid of Women with Prodomal Alzheimer's Disease
Gil-Bea, F. J., Solas, M., Solomon, A., Mugueta, C., Winblad, B. G., Kivipelto, M., Ramírez, M. J., & Cedazo-Mínguez, Á. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100795 · Cited by 90
Carvalho, C., Machado, N. J., Mota, P. C., Correia, S. C., Cardoso, S., Santos, R. X., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130005 · Cited by 89
The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7
Gatchel, J. R., Watase, K., Christina Thaller, B., Carson, J. P., Jafar‐Nejad, P., Shaw, C. A., Zu, T., Orr, H. T., & Zoghbi, H. Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711257105 · Cited by 89
Chesik, D., Keyser, J. D., & Wilczak, N. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9041-2 · Cited by 85
Niikura, T., Hashimoto, Y., Okamoto, T., Abe, Y., Yasukawa, T., Kawasumi, M., Hiraki, T., Kita, Y. A., Terashita, K., Kouyama, K., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01902.2001 · Cited by 84
Spescha, R. D., Shi, Y., Wegener, S., Keller, S., Weber, B., Wyss, M. T., Lauinger, N. D., Tabatabai, G., Paneni, F., Cosentino, F., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs331 · Cited by 84
Dupraz, S., Grassi, D., Karnas, D., Guil, A. F. N., Hicks, D., & Quiroga, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054462 · Cited by 84
Liu, W., Ye, P., OʼKusky, J. R., & D’Ercole, A. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22129 · Cited by 84
Developmental regulation of insulin in the mammalian central nervous system
Schechter, R., Whitmire, J., Holtzclaw, L. A., George, M., Harlow, R. D., & Devaskar, S. U. (1992) · Brain Research · doi:10.1016/0006-8993(92)90313-x · Cited by 81
Diabetes in Patients With Idiopathic Parkinson's Disease
Becker, C., Brobert, G., Johansson, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-0479 · Cited by 81
Incretin‐based therapies – review of the physiology, pharmacology and emerging clinical experience
Martin, J. H., Deacon, C. F., Gorrell, M. D., & Prins, J. B. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02439.x · Cited by 76
Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences
Beyer, K., & Ariza, A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d64 · Cited by 76
Diabetes preceding Parkinson's disease onset. A case–control study
D’Amelio, M., Ragonese, P., Callari, G., Benedetto, N. D., Palmeri, B., Terruso, V., Salemi, G., Famoso, G., Aridon, P., & Savettieri, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.013 · Cited by 76
Salehi, Z., Mashayekhi, F., & Naji, M. (2008) · BioFactors · doi:10.1002/biof.5520330202 · Cited by 74
Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
Godau, J., Herfurth, M., Kattner, B., Gasser, T., & Berg, D. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.175752 · Cited by 73
Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death
Zawada, W. M., Kirschman, D. L., Cohen, J., Heidenreich, K. A., & Freed, C. R. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0115 · Cited by 72
Qin, Z., Sun, Z., Huang, J., Hu, Y., Wu, Z., & Mei, B. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.047 · Cited by 71
Chowen, J. A., de Fonseca, F. R., Álvarez, E., Navarro, M. A., García‐Segura, L. M., & Blázquez, E. (1999) · Neuropeptides · doi:10.1054/npep.1999.0757 · Cited by 70
Rescue of α-synuclein cytotoxicity by insulin-like growth factors
Kao, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.089 · Cited by 69
Mashayekhi, F., Mirzajani, E., Naji, M., & Azari, M. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.08.013 · Cited by 68
IRS‐2 branch of IGF‐1 receptor signaling is essential for appropriate timing of myelination
Freude, S., Leeser, U., Müller, M., Hettich, M. M., Udelhoven, M., Schilbach, K., Tobe, K., Kadowaki, T., Köhler, C. N., Schröder, H., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05631.x · Cited by 66
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype
Miller, T. W., Shirley, T. L., Wolfgang, W. J., Kang, X., & Messer, A. C. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00063-7 · Cited by 65
Role of IGF-1 in glucose regulation and cardiovascular disease
Abbas, A., Grant, P. J., & Kearney, M. T. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.8.1135 · Cited by 64
Baskin, D. G., Sipols, A. J., Schwartz, M. W., & White, M. F. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90355-c · Cited by 63
Insulin‐like growth factor‐I receptors in human brain and pituitary gland: An autoradiographic study
Keyser, J. D., Wilczak, N., Backer, J. D., Herroelen, L., & Vauquelin, G. (1994) · Synapse · doi:10.1002/syn.890170309 · Cited by 61
Insulin in the cerebrospinal fluid
Plata‐Saláman, C. R. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80004-1 · Cited by 60
Lee, Y., Kim, Y.-H., Park, S.-J., Huh, J., Kim, S., Kim, S., Kim, J., Jeong, K.-J., Lee, K., Hong, Y., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130776 · Cited by 59
Picillo, M., Erro, R., Santangelo, G., Pivonello, R., Longo, K., Pivonello, C., Vitale, C., Amboni, M., Moccia, M., Colao, A., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6851-0 · Cited by 56
Jafferali, S., Dumont, Y., Sotty, F., Robitaille, Y., Quirion, R., & Kar, S. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<450::aid-syn10>3.0.co;2-j · Cited by 56
Lunetta, C., Serafini, M., Prelle, A. C., Magni, P., Dozio, E., Ruscica, M., Sassone, J., Colciago, C., Moggio, M. G., Corbo, M., et al. (2011) · Muscle & Nerve · doi:10.1002/mus.22288 · Cited by 53
Godau, J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.129 · Cited by 52
Numao, A., Suzuki, K., Miyamoto, M., Miyamoto, T., & Hirata, K. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.11.005 · Cited by 52
Schechter, R., Sadiq, H. F., & Devaskar, S. U. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.6.2186089 · Cited by 52
Effects of brain endogenous insulin on neurofilament and MAPK in fetal rat neuron cell cultures
Schechter, R., Yanovitch, T. L., Abboud, M., Johnson, G., & Gaskins, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00842-7 · Cited by 51
High insulinlike growth factor I is associated with cognitive decline in Huntington disease
Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., Hawajri, N. E., Bachoud‐Lévi, A., & Maison, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e62076 · Cited by 50
Gammeltoft, S., Fehlmann, M., & OBBERGHEN, E. V. (1985) · Biochimie · doi:10.1016/s0300-9084(85)80113-9 · Cited by 48
N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats
Krishnamurthi, R., Stott, S., Maingay, M., Faull, R. L. M., McCarthy, D., Gluckman, P. D., & Guan, J. (2004) · Neuroreport · doi:10.1097/01.wnr.0000127461.15985.07 · Cited by 46
Sun, X., Huang, L., Zhang, M., Sun, S., & Wu, Y. (2010) · Toxicology · doi:10.1016/j.tox.2010.01.001 · Cited by 45
Chung, J.-Y., Lee, S. J., Lee, S., Jung, Y. S., Ha, N., Seol, W., & Park, B.-J. (2011) · Neurosignals · doi:10.1159/000325028 · Cited by 43
Ye, P., Li, L., Lund, P. K., & D’Ercole, A. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00355-3 · Cited by 42
Dorn, A., Bernstein, H., Hahn, H.-J., ZIEGLER, M., & Rummelf�nger, H. (1981) · Histochemistry and Cell Biology · doi:10.1007/bf00508386 · Cited by 41
IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP
Nadjar, A., Berton, O., Guo, S., Leneuve, P., Doveró, S., Diguet, E., Tison, F., Zhao, B., Holzenberger, M., & Bézard, E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.009 · Cited by 41
Growth hormone secretion is impaired in amyotrophic lateral sclerosis
Morselli, L. L., Bongioanni, P., Genovesi, M., Licitra, R., Rossi, B., Murri, L., Rossi, G., Martino, E., & Gasperi, M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02609.x · Cited by 41
Nakade, Y., Tsukamoto, K., Pappas, T. N., & Takahashi, T. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.090 · Cited by 40
Insulin-like immunoreactivity in the human brain
Dorn, A., Bernstein, H., Rinne, A., Hahn, H.-J., & ZIEGLER, M. (1982) · Histochemistry and Cell Biology · doi:10.1007/bf00495838 · Cited by 40
Iozzo, P., Osman, S., Glaser, M., Knickmeier, M., Ferrannini, E., Pike, V. W., Camici, P. G., & Law, M. P. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00286-4 · Cited by 37
MATSUO, K., Niwa, M., Kurihara, M., Shigematsu, K., Yamashita, S., Ozaki, M., & Nagataki, S. (1989) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711415 · Cited by 32
Wang, X., Yang, W., Hölscher, C., Wang, Z., Cai, H., Li, Q., & Qi, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23181 · Cited by 32
Su, K., Savino, C., Marracci, G., Chaudhary, P., Yu, X., Morris, B., Galipeau, D., Giorgio, M., Forte, M. A., & BOURDETTE, D. N. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07972.x · Cited by 29
Multiple system atrophy is associated with changes in peripheral insulin‐like growth factor system
Pellecchia, M. T., Pivonello, R., Longo, K., Manfredi, M., Tessitore, A., Amboni, M., Pivonello, C., Rocco, M., Cozzolino, A., Colao, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23320 · Cited by 29
Lagarde, W. H., Benjamin, R., Heerens, A. T., Ye, P., Cohen, R. I., Moats‐Staats, B. M., & D’Ercole, A. J. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.12.006 · Cited by 18
Spatiotemporal Distribution of the Insulin-Like Growth Factor Receptor in the Rat Olfactory Bulb
Ferrari, C. C., Johnson, B. A., Leon, M., & Pixley, S. K. (2003) · Neurochemical Research · doi:10.1023/a:1021639926941 · Cited by 11
Merchenthaler (1999) · doi:10.1002/(sici)1096-9861(19990111)403:2<261::aid-cne8>3.0.co;2-5
Cited by
Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
Trial of Lixisenatide in Early Parkinson’s Disease
Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312323 · Cited by 369
Self-citationHerold, F., Törpel, A., Schega, L., & Müller, N. G. (2019) · European Review of Aging and Physical Activity · doi:10.1186/s11556-019-0217-2 · Cited by 349
Insulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
Zinc homeostasis and neurodegenerative disorders
Szewczyk, B. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00033 · Cited by 288
Metadata
- Authors
- Bassil, F., Fernagut, P.-O., Bezard, E., & Meissner, W. G.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 118
- Pages
- 1-18
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2079878023
- Cited by
- 309
- References
- 303
- FWCI
- 16.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.